MAPT and Alzheimer disease: Four of the scFvs (FTD-TDP1, FTD-TDP2, FTD-TDP3 and FTD-TDP4) have significantly higher reactivity to FTD-TDP and FTD-tau sera samples compared to AD sera samples, while the fifth scFv (FTD-TDP5) had high reactivity with all the FTD and AD samples.